Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Merkel Cell Carcinoma 2025.
This publication presents the first comprehensive, evidence-based clinical guidelines for Merkel cell carcinoma (MCC) in...
C-Reactive Protein Kinetics as Prognostic Biomarkers in Stage IV-Melanoma Treated With Immune Checkpoint Inhibitors in the Japanese Population: A Single-Center, Retrospective Cohort Study.
- Post category:Melanoma
- Reading time:1 min read
This retrospective study evaluated the prognostic significance of early changes in serum C-reactive protein (CRP) levels...
Germline Testing: The Therapeutic Biomarker You Can’t Afford to Miss
- Post category:Breast Cancer/Digestive (CRC, Stomach) System/Genitourinary (Prostate, Bladder) System/Gynecologic Cancer/Melanoma/Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
You may already be ordering germline testing at rates well above the national average — but across the U.S., most eligible patients still aren’t tested: Ovarian cancer: ~39% receive germline…